These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11127457)

  • 1. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting.
    Kastrati A; Koch W; Berger PB; Mehilli J; Stephenson K; Neumann FJ; von Beckerath N; Böttiger C; Duff GW; Schömig A
    J Am Coll Cardiol; 2000 Dec; 36(7):2168-73. PubMed ID: 11127457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty.
    Francis SE; Camp NJ; Burton AJ; Dewberry RM; Gunn J; Stephens-Lloyd A; Cumberland DC; Gershlick A; Crossman DC
    Heart; 2001 Sep; 86(3):336-40. PubMed ID: 11514491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.
    Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G
    Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.
    Koch W; Böttiger C; Mehilli J; von Beckerath N; Neumann FJ; Schömig A; Kastrati A
    Am J Cardiol; 2001 Nov; 88(10):1120-4. PubMed ID: 11703955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis.
    Dewberry R; Holden H; Crossman D; Francis S
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2394-400. PubMed ID: 11073843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms.
    Whyte M; Hubbard R; Meliconi R; Whidborne M; Eaton V; Bingle C; Timms J; Duff G; Facchini A; Pacilli A; Fabbri M; Hall I; Britton J; Johnston I; Di Giovine F
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):755-8. PubMed ID: 10934117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
    Böttiger C; Koch W; Lahn C; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Am Heart J; 2003 Nov; 146(5):855-61. PubMed ID: 14597935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty.
    Marculescu R; Mlekusch W; Exner M; Sabeti S; Michor S; Rumpold H; Mannhalter C; Minar E; Wagner O; Schillinger M
    Thromb Haemost; 2003 Sep; 90(3):491-500. PubMed ID: 12958619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus.
    Clay FE; Cork MJ; Tarlow JK; Blakemore AI; Harrington CI; Lewis F; Duff GW
    Hum Genet; 1994 Oct; 94(4):407-10. PubMed ID: 7927338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement.
    Kastrati A; Schömig A; Seyfarth M; Koch W; Elezi S; Böttiger C; Mehilli J; Schömig K; von Beckerath N
    Circulation; 1999 Mar; 99(8):1005-10. PubMed ID: 10051292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis.
    Klashami ZN; Mostafavi A; Roudbordeh MG; Abbasi A; Ebrahimi P; Asadi M; Amoli MM
    Mol Biol Rep; 2023 Oct; 50(10):8575-8587. PubMed ID: 37644369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.
    Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE
    Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies.
    Rider LG; Artlett CM; Foster CB; Ahmed A; Neeman T; Chanock SJ; Jimenez SA; Miller FW
    Clin Exp Immunol; 2000 Jul; 121(1):47-52. PubMed ID: 10886238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
    Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
    Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist gene polymorphism and traditional classification in obese women.
    Um JY; Kim HM; Mun SW; Song YS; Hong SH
    Int J Neurosci; 2006 Jan; 116(1):39-53. PubMed ID: 16318998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin 1beta and receptor antagonist gene polymorphisms with primary open-angle glaucoma.
    Lin HJ; Tsai SC; Tsai FJ; Chen WC; Tsai JJ; Hsu CD
    Ophthalmologica; 2003; 217(5):358-64. PubMed ID: 12913327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease.
    Manzoli A; Andreotti F; Varlotta C; Mollichelli N; Verde M; van de Greef W; Sperti G; Maseri A
    Cardiologia; 1999 Sep; 44(9):825-30. PubMed ID: 10609392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
    Chiou KR; Chung SL; Charng MJ
    J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems.
    Laham RJ; Carrozza JP; Berger C; Cohen DJ; Kuntz RE; Baim DS
    J Am Coll Cardiol; 1996 Oct; 28(4):820-6. PubMed ID: 8837554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.